All-atom simulations to studying metallodrugs/target interactions
Pavel Janoš1, Angelo Spinello1, Alessandra Magistrato1
1CNR-IOM c/o SISSA, Via Bonomea 265, 34136, Trieste, Italy.
Current Opinion in Chemical Biology
|August 12, 2020
Summary
Computational simulations reveal atomic-level details of metallodrug interactions with biological targets. This approach aids in understanding metallodrug mechanisms and designing new, selective therapies.
Area of Science:
- Medicinal Chemistry
- Computational Biology
- Biochemistry
Background:
- Metallodrugs are crucial for disease treatment and diagnosis.
- Metal ions' properties allow for targeted biomolecule interactions.
- Experimental data on metallodrugs lacks detailed mechanistic insights.
Purpose of the Study:
- To review the role of computer simulations in understanding metallodrug mechanisms.
- To highlight advances and challenges in computational approaches for metallodrug research.
- To provide insights for rational design of novel metallodrugs.
Main Methods:
- Literature review focusing on studies from the last two years.
- Analysis of computational methods applied to metallodrug-target interactions.
- Examination of atomic-level details of metallodrug mechanisms.
Main Results:
- Computational methods provide atomic-level understanding of metallodrug mechanisms.
- Simulations complement experimental data, revealing interaction intricacies.
- This knowledge is vital for developing selective metallodrugs.
Conclusions:
- Computer simulations are indispensable for deciphering metallodrug mechanisms.
- Advances in computational techniques enhance the rational design of metallodrugs.
- Future research should leverage simulations for novel therapeutic strategies.
Keywords:
CisplatinGold drugsMetallo-drug discoveryMetallo-drugsMolecular dynamicsQM/MMRuthenium drugsMore Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
920
10:52Multiscale Sampling of a Heterogeneous Water/Metal Catalyst Interface using Density Functional Theory and Force-Field Molecular Dynamics
Published on: April 12, 2019
13.2K
Related Concept Videos
01:25Drug-Receptor Bonds
4.0K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.0K
01:26Targets for Drug Action: Overview
9.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.8K
02:51Metal-Ligand Bonds
23.3K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
23.3K
02:40Ligand Binding Sites
14.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.7K
02:18The Equilibrium Binding Constant and Binding Strength
14.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.6K
01:29Drug-Receptor Interactions
7.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.1K